← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Gabaeron, Inc.
San Francisco, CA
$4,731,346
Total funding
2
Grants
Funding over time
peak $2M · FY2018–21$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$4,731,346 · 2
By mechanism
R44$4,731,346 · 2
Investigators at Gabaeron, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease$1,086,082
R44 · FY2021 · AG
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease$1,079,582
R44 · FY2020 · AG
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4$982,084
R44 · FY2019 · AG
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4$948,584
R44 · FY2020 · AG
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease$342,592
R44 · FY2019 · AG
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4$292,422
R44 · FY2018 · AG